Navigation Links
OICR funds Fluorinov Pharma Inc. to further develop its novel drug for the treatment of blood cancers
Date:6/7/2012

TORONTO, June 7, 2012 /PRNewswire/ -- The Ontario Institute for Cancer Research (OICR) today announced $1.5 million in funding over three years for the development of a new drug by Toronto-based Fluorinov Pharma, Inc. The drug, called FV-162, is a highly potent, orally-delivered small molecule proteasome inhibitor with significant advantages over drugs currently used to treat multiple myeloma and some forms of Non-Hodgkin's lymphoma.

"Our investment in Fluorinov Pharma Inc. will move FV-162 towards the market by helping it to meet the preclinical requirements of Health Canada and the FDA," said Mr. Frank Stonebanks, Vice-President, Commercialization and Chief Commercial Officer of OICR. "This novel drug is very promising and could improve the quality of life and outcomes of patients with certain blood cancers."

An important target for therapies treating blood cancers such as multiple myeloma is the proteasome, a part of the cell that recycles old proteins. While effective, the current proteasome inhibitor-based treatment is toxic and requires intravenous delivery. Additionally, some cancers develop resistance over time.

FV-162 has the potential to vastly improve the current treatment because it has lower toxicity, can be taken orally and has shown to be effective against drug-resistant cancer cells in the laboratory.  

Fluorinov Pharma Inc. developed FV-162 using a unique medicinal chemistry technology in which fluorine atoms are placed into drug candidates to enhance their pharmacokinetic properties and biological activities. FV-162 works by selectively inhibiting the chymotrypsin-like enzymatic activity of the proteasome.

OICR is supporting Fluorinov Pharma Inc.'s development of FV-162 through its Intellectual Property Development and Commercialization (IPDC) Fund, which was established to bridge the gap in the commercialization process between support from traditional public funding agencies and private investors.
'/>"/>

SOURCE Ontario Institute for Cancer Research (OICR)
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
2. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
3. InnoPharma Inc. Raises $8 Million in Venture Debt
4. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
5. Nouveau Life Pharmaceuticals (NOUV) to Begin Sales of Azul Instant™
6. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
7. Next Generation Pharmaceutical Manufacturing Summit Pushes the Envelope of Thought-Leadership at its September Summit in London
8. Attack on the Website of the American Pharmacists Association
9. SOCMAs Bulk Pharmaceuticals Task Force Welcomes House Passage of FDA Reform Act
10. Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension
11. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014  Cannabis Science, ... cannabis formulation-based drug development and related consulting, is ... of multiple strains of cannabis and European Union ... select the best strains for development of proprietary ... cannabis formulations to market for critical ailments such ...
(Date:7/31/2014)... , July 31, 2014 For the first ... watch the implantation of the SynCardia temporary Total Artificial ... matching video posted on the Journal of Visualized Experiments ... read the paper on the SynCardia Total Artificial Heart ... video accompanies "Implantation of the SynCardia Total Artificial Heart," ...
(Date:7/31/2014)... 2014 TB Alliance, a not-for-profit with ... and affordable treatments, announced the appointment of ... Affairs. Mr. Brock comes to TB Alliance having ... Relations for WWF International (formerly known as the ... will guide the TB Alliance,s resource development, advocacy ...
Breaking Medicine Technology:Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2
... post-surgery hormone therapy reduced risk of breast cancer return ... First Phase III data to substantiate anticancer effect of ... prevention of bone complications due to bone metastases, with ... Feb. 11 /PRNewswire/ -- A newly published ...
... test to help guide treatment decisionsANN ARBOR, Mich., Feb. ... Comprehensive Cancer Center have identified a panel of ... prostate cancer.The finding could lead to a simple test ... slow-growing and which require immediate, aggressive treatment.Results of the ...
Cached Medicine Technology:Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 2Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 3Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 4Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 5Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 6Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports 7Researchers Discover Metabolite Linked to Aggressive Prostate Cancer 2Researchers Discover Metabolite Linked to Aggressive Prostate Cancer 3
(Date:7/31/2014)... -- A class of medications previously linked to ... negatively affect their physical functioning according to investigators ... Center for Aging Research, the University of East ... In a systemic review of more than a ... with anticholinergic properties, they report that these drugs ...
(Date:7/31/2014)... application of vacuum pressure is a promising approach to ... an experimental study in the August issue of ... Congress of Neurological Surgeons . The journal is published ... of Wolters Kluwer Health . , "Mechanical ... area of the brainshows promise as a safe and ...
(Date:7/31/2014)... Las Vegas, Nevada (PRWEB) July 31, 2014 ... to provide next generation authentication services to cloud service ... way to utilize hardware protected multi-factor authentication with online ... the Internet's reliance on password-based authentication. It is the ... data breaches taking place around the globe. Instead of ...
(Date:7/31/2014)... 31, 2014 The Beryl Institute announces ... Board and four new members of its ... as the global community of practice and premier thought ... , Executive board members are industry leaders who advise ... valuable insight into market and industry trends. The advisory ...
(Date:7/31/2014)... Web Programming Services, a business partner of ... firm, has recently launched a new service named as ... for everyone, the company has announced a very nominal ... Programming Services has tailored the service after doing a ... likely expectations of the clients from their designers. This ...
Breaking Medicine News(10 mins):Health News:Common drugs adversely impair older adults' physical as well as cognitive functioning 2Health News:Vacuum treatment may limit damage after traumatic brain injury 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 3Health News:The Beryl Institute Announces Seven New Patient Experience Board Members 2Health News:The Beryl Institute Announces Seven New Patient Experience Board Members 3Health News:Web Programming Services Introduces Affordable Brochure Designing Service 2
... INDIANAPOLIS, Feb. 18 The Board of Directors of Eli ... Ralph Alvarez as a new member, effective April 1, 2009. ... of McDonald,s Corporation and is also a member of McDonald,s ... will serve on both the board,s finance committee and public ...
... Fla., Feb. 18 On March 2, 2009 at ... Florida will become Herzing University at a sign-changing event ... T-shirts and donating the profits to the American Cancer ... Heather Antonacci.This event represents the 44-year evolution of a ...
... R.I., Feb. 18 CVS Caremark Corporation (NYSE: ... into an agreement with the U.S. Federal Trade Commission ... Services Office for Civil Rights (OCR) concerning disposal of ... agreement resolves an investigation prompted by media reports from ...
... HOUSTON (Feb. 18, 2009) The fight ... will soon receive a boost from an ultrasound ... technology under development will allow early prediction of ... of fracture healing. , National Space Biomedical Research ...
... MeasuresWASHINGTON, Feb. 18 Patients across the United ... technology (HIT) law providing comprehensive privacy and security ... for psychotherapy records. The Health Information Technology for ... the economic stimulus package, was passed by the ...
... eligibility serviceFORT WORTH, Texas, Feb. 18 eRx ... services to the retail pharmacy industry, has announced ... solution, eRx CardFinder. The exclusive service, which was ... than 14,000 pharmacies nationwide."We place high significance on ...
Cached Medicine News:Health News:Ralph Alvarez Elected to Lilly Board of Directors 2Health News:Herzing College, Orlando Will Change Name to Herzing University and Host Sign-Changing Event on March 2, 2009 2Health News:Herzing College, Orlando Will Change Name to Herzing University and Host Sign-Changing Event on March 2, 2009 3Health News:CVS Caremark Issues Statement on Settlement Concerning Disposal of Patient Information at its Retail Stores 2Health News:SCAN: Delivering bone disorder diagnosis, fracture healing 2Health News:SCAN: Delivering bone disorder diagnosis, fracture healing 3Health News:Patients Gain Protections in Health Information Technology Law 2Health News:Patients Gain Protections in Health Information Technology Law 3Health News:eRx Network(R) Expands eRx CardFinder(TM) Reach 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: